Ingevity (NYSE: NGVT) reported Q4 EPS of $1.33, $0.56 better than the analyst estimate of $0.77. Revenue for the quarter came in at $325.6 million versus the consensus estimate of $283.26 million.

GUIDANCE:

Ingevity sees FY2021 revenue of $1.25-1.3 billion, versus the consensus of $1.27 billion.

For earnings history and earnings-related data on Ingevity (NGVT) click here.